Improvement of Parameter Estimations in Tumor Growth Inhibition Models on Xenografted Animals: Handling Sacrifice Censoring and Error Caused by Experimental Measurement on Larger Tumor Sizes-Reference-Cited by-同舟云学术

Improvement of Parameter Estimations in Tumor Growth Inhibition Models on Xenografted Animals: Handling Sacrifice Censoring and Error Caused by Experimental Measurement on Larger Tumor Sizes

Published:2016-06-21 Issue:5 Volume:18 Page:1262-1272
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Pierrillas Philippe B.,Tod Michel,Amiel Magali,Chenel Marylore,Henin Emilie

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1208/s12248-016-9936-8.pdf

Reference28 articles.

1. Rubin DB. Inference and missing data. Biometrika. 1976;63(3):581–90. doi: 10.1093/biomet/63.3.581 .

2. Little R, Rubin DB. Statistical analysis with missing data, 2nd Edition. John Wiley and Sons ed: John Wiley and Sons; 2002.

3. Beal SL. Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn. 2001;28(5):481–504.

4. Sausville EA, Burger AM. Contributions of human tumor xenografts to anticancer drug development. Cancer Res. 2006. doi: 10.1158/0008-5472.CAN-05-3627 .

5. Rocchetti M, Simeoni M, Pesenti E, De Nicolao G, Poggesi I. Predicting the active doses in humans from animal studies: a novel approach in oncology. Eur J Cancer. 2007;43(12):1862–8. doi: 10.1016/j.ejca.2007.05.011 .

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic characterization of oscillatory patterns in unperturbed tumor growth dynamics: The interplay between cancer cells and components of tumor microenvironment;PLOS Computational Biology;2023-10-04

2. Utilization of data below the analytical limit of quantitation in pharmacokinetic analysis and modeling: promoting interdisciplinary debate;Bioanalysis;2018-08-01

3. Current mathematical models for cancer drug discovery;Expert Opinion on Drug Discovery;2017-06-22